These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6520828

  • 1. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
    Via CS, Allen RC, Welton RC.
    J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
    [Abstract] [Full Text] [Related]

  • 2. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
    Starkebaum G, Arend WP.
    J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
    [Abstract] [Full Text] [Related]

  • 3. Impaired monocyte motility in sera from patients with systemic lupus erythematosus.
    Sturfelt G, Linder C, Sjöholm AG, Svensson B.
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):151-8. PubMed ID: 6880748
    [Abstract] [Full Text] [Related]

  • 4. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
    Medof ME, Oger JJ, Antel JP, Prince GM.
    J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
    [Abstract] [Full Text] [Related]

  • 5. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA, Morris SM, Dash A, Peters DK.
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [Abstract] [Full Text] [Related]

  • 6. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
    Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS.
    Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095
    [Abstract] [Full Text] [Related]

  • 7. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A, Cárdenas-Mondragón G.
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Jan; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Circulating immune complexes in systemic lupus erythematosus.
    Cano PO, Jerry LM, Sladowski JP, Osterland CK.
    Clin Exp Immunol; 1977 Aug; 29(2):197-204. PubMed ID: 302768
    [Abstract] [Full Text] [Related]

  • 14. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 15. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC, Malone CC, Meyers C, Decker P, Muller S.
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [Abstract] [Full Text] [Related]

  • 16. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH, Rasmussen JM, Voss A, Junker P, Leslie RG.
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [Abstract] [Full Text] [Related]

  • 17. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Kumar S, Isenberg DA.
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [Abstract] [Full Text] [Related]

  • 20. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Jul; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.